Literature DB >> 9734649

Molecular cloning and functional analysis of the CD33 promoter.

M P Bodger1, D N Hart.   

Abstract

CD33 is a leucocyte differentiation antigen restricted to myeloid cells in blood and bone marrow. Two mRNA transcripts encoding CD33 are observed in leukaemic cell lines. The smaller transcript of 1.5 kb is comparable in size to the isolated CD33 cDNA but the origin of the larger 1.8 kb transcript is unknown. To study the regulation of human CD33 expression, a 5' genomic clone from the CD33 gene was isolated and studied for promoter activity. The clone, although lacking a TATAA box, exhibits other sequences characteristic of a promoter. Two transcriptional start sites were identified, 414 and 527 nucleotides 5' of the ATG initiation codon, suggesting that these sites are used to generate the 1.8 kb transcript observed in CD33+ cell lines. The CD33 genomic sequence directed high expression of a luciferase reporter gene in myeloid cell lines. Using deletion mutants of the promoter sequence, maximal expression was localized to the first 220 bp 5' of the ATG initiation codon. Site-directed mutagenesis of an Sp-1 and PU.1 binding site within this region showed that the PU.1, but not Sp-1, was critical for CD33 expression in myeloid lines. Given the restricted expression of CD33 on haemopoietic cells, the identification of the CD33 promoter may be useful for the study of transcription factors that regulate gene expression during early myeloid differentiation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9734649     DOI: 10.1046/j.1365-2141.1998.00863.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

1.  Induction of multilineage markers in human myeloma cells and their down-regulation by interleukin 6.

Authors:  Shangqin Liu; Ken-ichiro Otsuyama; Zi Ma; Saeid Abroun; Karim Shamsasenjan; Jakia Amin; Hideki Asaoku; Michio M Kawano
Journal:  Int J Hematol       Date:  2007-01       Impact factor: 2.490

2.  Critical role for Ets, AP-1 and GATA-like transcription factors in regulating mouse Toll-like receptor 4 (Tlr4) gene expression.

Authors:  Thierry Roger; Isabelle Miconnet; Anne-Laure Schiesser; Hirofumi Kai; Kensuke Miyake; Thierry Calandra
Journal:  Biochem J       Date:  2005-04-15       Impact factor: 3.857

3.  IL-6-induced activation of MYC is responsible for the down-regulation of CD33 expression in CD33+ myeloma cells.

Authors:  Karim Shamsasenjan; Ken-Ichiro Otsuyama; Saeid Abroun; Mohd S Iqbal; Maged S Mahmoud; Hideki Asaoku; Michio M Kawano
Journal:  Int J Hematol       Date:  2009-03-04       Impact factor: 2.490

Review 4.  Antibody-based therapy of acute myeloid leukemia with gemtuzumab ozogamicin.

Authors:  Andrew J Cowan; George S Laszlo; Elihu H Estey; Roland B Walter
Journal:  Front Biosci (Landmark Ed)       Date:  2013-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.